TR200402073T4 - Gaba A reseptör olarak benzodiazepin türevleri - Google Patents

Gaba A reseptör olarak benzodiazepin türevleri

Info

Publication number
TR200402073T4
TR200402073T4 TR2004/02073T TR200402073T TR200402073T4 TR 200402073 T4 TR200402073 T4 TR 200402073T4 TR 2004/02073 T TR2004/02073 T TR 2004/02073T TR 200402073 T TR200402073 T TR 200402073T TR 200402073 T4 TR200402073 T4 TR 200402073T4
Authority
TR
Turkey
Prior art keywords
alkyl
phenyl
halogen
hydrogen
alkoxy
Prior art date
Application number
TR2004/02073T
Other languages
English (en)
Turkish (tr)
Inventor
Masciadri Raffaello
William Thomas Andrew
Wichmann Juergen
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of TR200402073T4 publication Critical patent/TR200402073T4/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2004/02073T 2000-11-16 2001-11-08 Gaba A reseptör olarak benzodiazepin türevleri TR200402073T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16

Publications (1)

Publication Number Publication Date
TR200402073T4 true TR200402073T4 (tr) 2004-10-21

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02073T TR200402073T4 (tr) 2000-11-16 2001-11-08 Gaba A reseptör olarak benzodiazepin türevleri

Country Status (40)

Country Link
US (1) US6743789B2 (enExample)
EP (1) EP1337535B1 (enExample)
JP (1) JP4088151B2 (enExample)
KR (1) KR100504300B1 (enExample)
CN (1) CN1191255C (enExample)
AR (1) AR031345A1 (enExample)
AT (1) ATE268776T1 (enExample)
AU (2) AU1700702A (enExample)
BG (1) BG107817A (enExample)
BR (1) BR0115393A (enExample)
CA (1) CA2427576C (enExample)
CZ (1) CZ295256B6 (enExample)
DE (1) DE60103776T2 (enExample)
DK (1) DK1337535T3 (enExample)
EC (1) ECSP034607A (enExample)
ES (1) ES2220831T3 (enExample)
GC (1) GC0000375A (enExample)
GT (1) GT200100230A (enExample)
HR (1) HRP20030360A2 (enExample)
HU (1) HUP0303281A3 (enExample)
IL (1) IL155813A0 (enExample)
JO (1) JO2359B1 (enExample)
MA (1) MA26962A1 (enExample)
MX (1) MXPA03004251A (enExample)
MY (1) MY141675A (enExample)
NO (1) NO324706B1 (enExample)
NZ (1) NZ525413A (enExample)
PA (1) PA8532401A1 (enExample)
PE (1) PE20020583A1 (enExample)
PL (1) PL362925A1 (enExample)
PT (1) PT1337535E (enExample)
RU (1) RU2278865C2 (enExample)
SI (1) SI1337535T1 (enExample)
SK (1) SK7232003A3 (enExample)
TR (1) TR200402073T4 (enExample)
TW (1) TWI239333B (enExample)
UY (1) UY27026A1 (enExample)
WO (1) WO2002040487A2 (enExample)
YU (1) YU35603A (enExample)
ZA (1) ZA200303435B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
EP1634879A4 (en) * 2003-06-19 2007-09-05 Daiichi Seiyaku Co METHOD FOR THE SELECTIVE INTRODUCTION OF AN AMINO SUBSTITUENT
EP2343073A3 (en) 2003-12-11 2011-10-12 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CA2577060A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
MX2007004250A (es) * 2004-10-12 2007-06-12 Hoffmann La Roche Derivados de imidazo[1,5-a]triazolo[1,5-d]benzodiazepina para el tratamiento de trastornos cognitivos.
CA2584757C (en) * 2004-10-20 2012-07-03 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
RU2007112940A (ru) * 2004-10-20 2008-11-27 Ф.Хоффманн-Ля Рош Аг (Ch) Производные имидазобензодиазепина
KR100923393B1 (ko) * 2004-12-14 2009-10-23 에프. 호프만-라 로슈 아게 Gaba 수용체 조절제로서 테트라사이클릭이미다조-벤조다이아제핀
EP1924712B1 (en) * 2005-08-03 2018-10-03 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
ATE477255T1 (de) * 2005-10-11 2010-08-15 Hoffmann La Roche Imidazobenzdiazepinderivate
JP2009513672A (ja) * 2005-10-31 2009-04-02 ブレインセルス,インコーポレイティド 神経発生のgaba受容体媒介調節
WO2009139916A1 (en) * 2008-05-16 2009-11-19 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate hsp90 activity
CA2739900C (en) * 2008-11-18 2016-11-08 F. Hoffmann-La Roche Ag Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
NZ592076A (en) * 2008-11-28 2012-06-29 Hoffmann La Roche Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
MX383953B (es) 2010-11-15 2025-03-14 Agenebio Inc Derivados de piridazina, composiciones y metodos para tratar deterioro cognitivo.
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
WO2014047413A1 (en) * 2012-09-21 2014-03-27 Uwm Research Foundation, Inc. Novel gabaa agonists and methods of using to control airway hyperresponsiveness and inflammation in asthma
MX381561B (es) * 2013-12-20 2025-03-12 Agenebio Inc Derivados de benzodiazepina, composiciones, y métodos para tratar el deterioro cognitivo.
US10815242B2 (en) * 2015-06-19 2020-10-27 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
CA3104478A1 (en) * 2018-06-19 2019-12-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
WO2024039886A1 (en) 2022-08-19 2024-02-22 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (enExample) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
MY141675A (en) 2010-06-15
MXPA03004251A (es) 2003-09-22
AR031345A1 (es) 2003-09-17
BR0115393A (pt) 2004-07-06
SI1337535T1 (en) 2004-10-31
JP2004517070A (ja) 2004-06-10
DE60103776D1 (de) 2004-07-15
DE60103776T2 (de) 2005-07-14
IL155813A0 (en) 2003-12-23
TWI239333B (en) 2005-09-11
DK1337535T3 (da) 2004-10-25
WO2002040487A2 (en) 2002-05-23
CN1191255C (zh) 2005-03-02
NO324706B1 (no) 2007-12-03
GT200100230A (es) 2002-07-04
YU35603A (sh) 2006-05-25
BG107817A (bg) 2004-07-30
SK7232003A3 (en) 2004-03-02
PT1337535E (pt) 2004-09-30
CZ295256B6 (cs) 2005-06-15
CA2427576A1 (en) 2002-05-23
ATE268776T1 (de) 2004-06-15
AU1700702A (en) 2002-05-27
HUP0303281A3 (en) 2005-05-30
HRP20030360A2 (en) 2005-04-30
KR20030045192A (ko) 2003-06-09
AU2002217007B2 (en) 2006-11-30
UY27026A1 (es) 2002-06-20
PA8532401A1 (es) 2002-08-26
JP4088151B2 (ja) 2008-05-21
HUP0303281A2 (hu) 2004-01-28
EP1337535B1 (en) 2004-06-09
CZ20031597A3 (cs) 2003-11-12
NO20032208L (no) 2003-05-15
ECSP034607A (es) 2003-06-25
JO2359B1 (en) 2006-12-12
NO20032208D0 (no) 2003-05-15
RU2003116895A (ru) 2005-02-20
WO2002040487A3 (en) 2002-09-26
US6743789B2 (en) 2004-06-01
CN1474820A (zh) 2004-02-11
HK1062442A1 (en) 2004-11-05
MA26962A1 (fr) 2004-12-20
CA2427576C (en) 2007-11-06
GC0000375A (en) 2007-03-31
ES2220831T3 (es) 2004-12-16
PE20020583A1 (es) 2002-07-06
EP1337535A2 (en) 2003-08-27
NZ525413A (en) 2005-02-25
RU2278865C2 (ru) 2006-06-27
US20020103371A1 (en) 2002-08-01
PL362925A1 (en) 2004-11-02
KR100504300B1 (ko) 2005-07-28
ZA200303435B (en) 2004-08-05

Similar Documents

Publication Publication Date Title
TR200402073T4 (tr) Gaba A reseptör olarak benzodiazepin türevleri
DK1200390T3 (da) Fremstilling af N-substituerede 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamider
CO4770975A1 (es) Derivados de quinazolina sustituidos
NZ513561A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
JP2002510622A5 (enExample)
CY1109835T1 (el) Πυρανονες χρησιμες ως αναστολεις της atm
PE20090477A1 (es) Derivados de oxazol como inhibidores de los canales de sodio
HU9501622D0 (en) 1,4-benzodiazepine derivatives and their use as cck-mudulators
WO2002044153A8 (en) 4-6-diphenyl pyridine derivatives as antiinflammatory agents
ATE182889T1 (de) Bicyclische amidinderivate als no-synthetase inhibitoren
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
HRP20040230B1 (hr) Agonisti muskarina
CO5080801A1 (es) Inhibidores de proteasas
IT1320162B1 (it) Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
ATE229996T1 (de) Starkes grünstichiges gelbes disazopigment
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
ATE102199T1 (de) 4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen.
MXPA03009158A (es) Azepinas y diazepinas bi y triciclicas substituidas de n-bifenilcarbonil y n-fenilpiridilcarbonil como agonistas de la vasopresion.
EA200200973A1 (ru) Пиридазинилфенилгидразоны, применяемые при застойной сердечной недостаточности
WO2006092507A8 (fr) Derives de 1 ,2,4-triazines, leur preparation et leur application en therapeutique humaine
ES2010089A6 (es) Procedimiento para la obtencion de n-oxidos de gamma-carbolina antipsicoticos.
EP1619040A3 (en) Thermal transfer recording material and thermal transfer recording method
CO5180634A1 (es) Sulfonamidas sustituidas con naftilo
CA2361390A1 (en) Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
ZA938230B (en) Substituted benzyl carbamates with herbicidal properties